Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US62855J1043
Ticker MYGN
Company MYRIAD GENETICS
Currency $
Price
Aware Investor Index (AII) 0.1202
Recommendation HOLD
P/E 33.39
ROE 13.25 %
Capitalization 3,310,852,000 $
Dividend Yield 0.00 %
P/S 4.39
AII Position 465
P/E Position 447
ROE Position 309
Capitalization Position 647
Dividend Yield Position 629
Sales 753,800,000 $
10-Year Average Earnings 99,152,600 $
Shares Outstanding 72,400,000
Equity 748,100,000 $
Dividend per Share 0 $
Industry Biotechnology
Country United States
MYRIAD GENETICS Investor Relations Web Site http://investor.myriad.com







Sales:

YEAR MONTH AMOUNT
2016 6 753,800,000.00 $
2015 6 723,100,000.00 $
2014 6 778,216,000.00 $
2013 6 613,165,000.00 $

Earnings:

YEAR MONTH AMOUNT
2016 6 125,300,000.00 $
2015 6 80,200,000.00 $
2014 6 176,225,000.00 $
2013 6 147,139,000.00 $
2012 6 112,151,000.00 $
2011 6 100,710,000.00 $
2010 6 152,303,000.00 $
2009 6 84,615,000.00 $
2008 6 47,845,000.00 $
2007 6 -34,962,000.00 $

Equity:

YEAR MONTH AMOUNT
2016 6 748,100,000.00 $
2015 6 662,100,000.00 $
2014 6 718,998,000.00 $
2013 6 728,594,000.00 $
2012 6 635,660,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2016 6 72,400,000
2015 6 74,500,000
2014 6 78,182,000
2013 6 83,327,000
2012 6 86,465,000

 












Bloomberg News for MYRIAD GENETICS:

Feb 10, 2012
Nasdaq Short Interest as of Jan. 31
620 87,737 MYRX MYREXIS INC 171,102 212,920 27,673 MYGN MYRIAD GENETICS 2,889,711 2,829,144 719,834 NABI NABI BIOPHARMA...
May 1, 2012
U.S. Companies Reporting Higher Quarterly EPS, May 1
Q12 % CHG Q/E ======================================================================== MYGN# MYRIAD GENETICS 0.34 0.31 9.7 0.32 6.3 Mar GLAD# GLADSTONE CAP CO ...
Aug 9, 2011
U.S. Companies Reporting Positive EPS Surprises, Aug. 9
2.84 10.66 HPT HOSPITALITY PROP 0.89 0.81 9.9 0.86 3.5 2.45 12.86 MYGN# MYRIAD GENETICS 0.30 0.39 -23.1 0.29 3.4 1.07 5.97 TNGN# TENGION INC...
Aug 9, 2011
U.S. Companies Reporting Earnings on Aug. 9
99.5 0.08 NM Jun MRVC# MRV COMM 0.01 na na 0.01 0.0 Jun MYGN# MYRIAD GENETICS 0.30 0.39 -23.1 0.29 3.4 Jun TICKER ...
Aug 8, 2011
Implied Stock-Price Moves for U.S. Companies Reporting Results
53 7.22 08/09 Bef-mkt FOSL FOSSIL INC 1.02 8.44 8.30 08/09 Aft-mkt MYGN MYRIAD GENETICS 1.02 9.71 9.54 08/09 SPWRA SUNPOWER CORP-A ...
Jun 30, 2008
H&R Block, Level 3, Wachovia, Whole Foods: U.S. Equity Movers
networks, saying lower valuations for telephone companies may hurt the stock. Myriad Genetics Inc. (MYGN US) fell the most since Nov. 7, losing 5.1 percent to $45.50. The biotech company's Alzheimer's...
Dec 30, 2005
S&P's Top-Shelf Selections
of $135 billion for Procter & Gamble (PG ) to a low of $700 million for Myriad Genetics (MYGN ). By contrast, the median market capitalization of the S&P 500 index is about $10.3 billion...
Aug 26, 2003
CS First Boston Lowers Myriad Genetics to 'Neutral'
Credit Suisse First Boston downgraded Myriad Genetics (MYGN ) to neutral from outperform. Analyst Mark Augustine says...
May 22, 2001
Reaping the Bush Dividend
one called Human Genome Sciences (HGSI ), and there's another one called Myriad Genetics (MYGN ). I'm not necessarily recommending those firms as the best ones to look at, but I'm saying...
Dec 14, 2006
S&P Ups Oracle to Strong Buy
reflecting a multiple reduction due to the aforementioned sales risks. Myriad Genetics (MYGN): Cuts to 3 STARS (hold) from 4 STARS (buy) Analyst: Paul Starsia Our downgrade comes...


Google News for MYRIAD GENETICS:

GlobeNewswire (press release) - 1 day ago
DEADLINE ALERT: Shareholder Class Action Against Myriad ...
RADNOR, Pa., May 26, 2018 (GLOBE NEWSWIRE) -- Kaskela Law LLC alerts Myriad Genetics, Inc. (NASDAQ:MYGN) (“Myriad” or the ...
Seeking Alpha - 8 May 2018
Myriad Genetics (MYGN) Q3 2018 Results - Earnings Call Transcript
Myriad Genetics, Inc. (NASDAQ:MYGN) Q3 2018 Earnings Call May 8, 2018 7:30 AM ET. Executives. Scott Gleason - Myriad Genetics, Inc.
Nasdaq
Myriad Genetics Named to Forbes 2018 List of America's Best ...
SALT LAKE CITY, May 02, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and ...
Benzinga
Better Buy: Opko Health, Inc. (OPK) vs. Myriad Genetics (MYGN)
Myriad Genetics saw its share price plunge close to 40% earlier in 2018, but a strong rebound has the stock price close to where it began the ...
Post Analyst
Myriad Announces Seven New Payer Coverage Decisions for ...
SALT LAKE CITY, May 23, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a worldwide leader in personalized medicine ...
GlobeNewswire (press release) - 2 May 2018
Myriad Genetics Reports Fiscal Third-Quarter 2018 Financial Results
SALT LAKE CITY, May 08, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a global leader in molecular diagnostics and ...
Digital Journal
MYGN ALERT: Rosen Law Firm Reminds Myriad Genetics, Inc ...
NEW YORK, May 19, 2018 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Myriad ...
Macon Daily
Can Molecular Diagnostics Drive Myriad's (MYGN) Q3 Earnings?
Similar to last quarter, Myriad Genetics is expected to gain from strong Molecular Diagnostics performance, led by solid contributions from the ...
Motley Fool - 18 May 2018
Myriad Genetics (MYGN) Shareholder Tieton Capital Management ...
Wells Fargo Mn reported 0.01% in Myriad Genetics, Inc. (NASDAQ:MYGN). Nordea Mgmt Ab owns 71,278 shares. New York State Teachers ...
The Ledger Gazette
Kaskela Law LLC: Shareholder Class Action Filed Against Myriad ...
... Kaskela Law LLC announces that a shareholder class action lawsuit has been filed against Myriad Genetics, Inc. (NASDAQ:MYGN) (“Myriad” ...


Back